FAM20C and triple-negative breast carcinoma: Studies have indicated that FAM20C might be a biomarker for diverse cancers, including triple-negative breast cancer (Tagliabracci et al., 2015), lung adenocarcinoma (Li H. et al., 2020), and stomach adenocarcinoma (Liu et al., 2021).